TESSERACT LIFE SCIENCES
Live / Applied — Suspended — suspension letter mailed (as of 17 Aug 2026)
What this means for you
Not registered yet, but its 30 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99422380
- Mark type
- Word mark
- Filed
- 30 Sept 2025
Goods and services
- Class 041 — Education and entertainment services: Providing online publications in the nature of articles, abstracts, patient guides, and practitioner guides relating to nutrient delivery, nutrient bioavailability, cardiovascular health, immune health, gastrointestinal health, neurological health, musculoskeletal health, pulmonary health, liver health, endocrine health, and healthy aging
- Class 044 — Medical, beauty and agricultural services: Providing medical information and opinion commentary online for physicians, patients, and consumers involved in or interested in nutrient delivery, nutrient bioavailability, cardiovascular health, immune health, gastrointestinal health, neurological health, musculoskeletal health, pulmonary health, liver health, endocrine health, and healthy aging
Owner
- Tesseract Medical Research, LLC, Laguna Hills, CA, US
Prior registrations
Prosecution history
- 17 Aug 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 17 Aug 2026 — LETTER OF SUSPENSION E-MAILED
- 17 Aug 2026 — SUSPENSION LETTER WRITTEN
- 20 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jun 2026 — NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 20 Jun 2026 — NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 20 Jun 2026 — REPORT UNRESPONSIVE AMENDMENT - COMPLETED
- 24 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION E-MAILED
- 25 Feb 2026 — NON-FINAL ACTION WRITTEN